Suppr超能文献

前列腺根治术后淋巴水肿的诊治:有哪些新进展?

Diagnosis and Treatment of Post-Prostatectomy Lymphedema: What's New?

机构信息

Postgraduation School in Radiodiagnostics, University of Milan, 20122 Milan, Italy.

Postgraduation School in Plastic Surgery, University of Milan, Via Festa del Perdono, 7, 20122 Milan, Italy.

出版信息

Curr Oncol. 2023 Apr 25;30(5):4512-4526. doi: 10.3390/curroncol30050341.

Abstract

Lymphedema is a chronic progressive disorder that significantly compromises patients' quality of life. In Western countries, it often results from cancer treatment, as in the case of post-radical prostatectomy lymphedema, where it can affect up to 20% of patients, with a significant disease burden. Traditionally, diagnosis, assessment of severity, and management of disease have relied on clinical assessment. In this landscape, physical and conservative treatments, including bandages and lymphatic drainage have shown limited results. Recent advances in imaging technology are revolutionizing the approach to this disorder: magnetic resonance imaging has shown satisfactory results in differential diagnosis, quantitative classification of severity, and most appropriate treatment planning. Further innovations in microsurgical techniques, based on the use of indocyanine green to map lymphatic vessels during surgery, have improved the efficacy of secondary LE treatment and led to the development of new surgical approaches. Physiologic surgical interventions, including lymphovenous anastomosis (LVA) and vascularized lymph node transplant (VLNT), are going to face widespread diffusion. A combined approach to microsurgical treatment provides the best results: LVA is effective in promoting lymphatic drainage, bridging VLNT delayed lymphangiogenic and immunological effects in the lymphatic impairment site. Simultaneous VLNT and LVA are safe and effective for patients with both early and advanced stages of post-prostatectomy LE. A new perspective is now represented by the combination of microsurgical treatments with the positioning of nano fibrillar collagen scaffolds (BioBridgeTM) to favor restoring the lymphatic function, allowing for improved and sustained volume reduction. In this narrative review, we proposed an overview of new strategies for diagnosing and treating post-prostatectomy lymphedema to get the most appropriate and successful patient treatment with an overview of the main artificial intelligence applications in the prevention, diagnosis, and management of lymphedema.

摘要

淋巴水肿是一种慢性进行性疾病,严重影响患者的生活质量。在西方国家,它通常是癌症治疗的结果,如根治性前列腺切除术后淋巴水肿,其发病率可高达 20%,给患者带来了沉重的疾病负担。传统上,疾病的诊断、严重程度评估和管理依赖于临床评估。在这种情况下,物理和保守治疗,包括绷带和淋巴引流,效果有限。成像技术的最新进展正在彻底改变这种疾病的治疗方法:磁共振成像在鉴别诊断、严重程度的定量分类和最合适的治疗计划方面显示出令人满意的结果。基于吲哚菁绿在手术中对淋巴管进行绘图的显微外科技术的进一步创新,提高了继发性淋巴水肿治疗的疗效,并开发了新的手术方法。生理手术干预,包括淋巴静脉吻合术(LVA)和带血管淋巴结移植(VLNT),将得到广泛应用。显微外科治疗的联合方法提供了最佳的结果:LVA 可有效促进淋巴引流,桥接 VLNT 在淋巴损伤部位延迟的淋巴管生成和免疫效应。同时进行 VLNT 和 LVA 对早期和晚期前列腺切除术后淋巴水肿患者均安全有效。目前,一个新的观点是将显微外科治疗与纳米纤维胶原支架(BioBridgeTM)的定位相结合,以促进恢复淋巴功能,从而实现更好和持续的体积减少。在这篇叙述性综述中,我们提出了一种新的策略,用于诊断和治疗前列腺切除术后淋巴水肿,以获得最适合和成功的患者治疗,并概述了人工智能在预防、诊断和管理淋巴水肿方面的主要应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16a9/10217297/5e6bf76b091d/curroncol-30-00341-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验